Quantcast

Latest HYCOR Biomedical Inc. Stories

2011-07-26 10:41:00

GARDEN GROVE, Calif., July 26, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products, today announced that it has signed an agreement with Eurospital--a manufacturer of pharmaceutical products, medical-surgical and diagnostic devices--to license its tTG biomarker in all countries covered by the patent (excluding the US and Canada) for its ability to diagnose celiac disease. HYCOR today also announced that it has signed an agreement...

2011-07-19 10:30:00

GARDEN GROVE, Calif., July 19, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products, today announced that Sean-Xavier Neath, M.D., Ph.D., has been appointed as Chief Medical Officer (CMO). In this role, Dr. Neath will support the company as it works to expand its product lines and provide additional support for customers. "We are pleased to welcome Dr. Neath to the HYCOR team and are confident he will have great impact on key...

2011-05-16 08:00:00

GARDEN GROVE, Calif., May 16, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets, together with owner Linden, LLC, today announced the appointments of Vijay Aggarwal, Ph.D. and James Koziarz, Ph.D., to its Board of Directors as part of its global growth strategy. "We are thrilled to welcome Drs. Aggarwal and Koziarz to the HYCOR team and are confident they will have...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related